Nanopore long-read sequencing for the critically ill facilitates ultrarapid diagnostics and urgent clinical decision making

Critically ill pediatric patients often have genetic disorders requiring a rapid diagnosis to guide urgent care decisions. Standard genetic testing typically takes weeks and requires multiple tests. Nanopore long-read genome sequencing (LR-GS) delivers genome-wide results within days as a one-test-fits-all solution. As one of the first centers in Europe, we implement ultrarapid LR-GS for critically ill patients. We enrolled 26 critically ill patients (median age 2 months) suspected of having a genetic disorder at the intensive care unit to perform (ultra)rapid nanopore LR-GS alongside standard genomic care. We compared diagnostic yield, turnaround time (TAT), and evaluated the impact on clinical decision making. In 11/26 cases a genetic diagnosis was made with (ultra)rapid LR-GS. From sample receipt to result, the average TAT was 5.3 days (range 2.0-10.8) for LR-GS and 18.4 days (range 6.1-29.1) for standard genomic care. DNA methylation analysis from LR-GS expedited the diagnosis in 3/26 cases. In 7/11 solved cases ultrarapid LR-GS led to immediate adjustments in patient care, e.g., medication switch or termination of treatment. Our findings underscore the clinical impact of ultrarapid LR-GS, including added value of methylation analysis, for critically ill patients and highlight existing challenges, paving the way to ultrarapid LR-GS integration into standard diagnostics.

Authors

Institutions

Publication Details

Journal
European Journal of Human Genetics
Published
2025-10-20
DOI
https://doi.org/10.1038/s41431-025-01959-x
Citations
3
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
5.45

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nanopore long-read sequencing for the critically ill facilitates ultrarapid diagnostics and urgent clinical decision making

Yolande van Bever, Désirée Y. van Haaften–Visser, Judith M.A. Verhagen, Federico Ferraro et al.
3 citations
European Journal of Human Genetics
Genomics and Rare Diseases
5.45
article

Nanopore long-read sequencing for the critically ill facilitates ultrarapid diagnostics and urgent clinical decision making

Yolande van Bever, Désirée Y. van Haaften–Visser, Judith M.A. Verhagen, Federico Ferraro, Marc Sylva, Wouter P. te Rijdt, Tjakko J. van Ham, Bianca M. de Graaf, Nienke van Engelen, Rachel Schot, Dmitrijs Rots, Laura Donker Kaat, Virginie J. M. Verhoeven, Bastiaan T van Dijk, Esther Nibbeling, Merel O. Mol, Tahsin Stefan Barakat, Rebekkah J. Hitti‐Malin, Martina Wilke, Daphne Heijsman, Marjon van Slegtenhorst, Sander Lamballais, Hennie T. Brüggenwirth, Raoul van de Graaf, Peter M. van Hasselt, Mark Drost, Hanna IJspeert, Els Wauters, Frank Sleutels, Herma C. van der Linde, Jona Mijalkovic, Dagmar I. Vos, Daphne J. Smits, Yvonne Hendriks, Tjitske Kleefstra, Alice S. Brooks, Lies H. Hoefsloot, Geert Geeven, Christophe Debuy, Līvija Bārdiņa, Glenn Huijbregts, Diënna Nawawi, Nadine Nederpelt, Eva L. M. Ulenkate, Monique Van Veghel – Plandsoen
article en
3 citations

Abstract

Critically ill pediatric patients often have genetic disorders requiring a rapid diagnosis to guide urgent care decisions. Standard genetic testing typically takes weeks and requires multiple tests. Nanopore long-read genome sequencing (LR-GS) delivers genome-wide results within days as a one-test-fits-all solution. As one of the first centers in Europe, we implement ultrarapid LR-GS for critically ill patients. We enrolled 26 critically ill patients (median age 2 months) suspected of having a genetic disorder at the intensive care unit to perform (ultra)rapid nanopore LR-GS alongside standard genomic care. We compared diagnostic yield, turnaround time (TAT), and evaluated the impact on clinical decision making. In 11/26 cases a genetic diagnosis was made with (ultra)rapid LR-GS. From sample receipt to result, the average TAT was 5.3 days (range 2.0-10.8) for LR-GS and 18.4 days (range 6.1-29.1) for standard genomic care. DNA methylation analysis from LR-GS expedited the diagnosis in 3/26 cases. In 7/11 solved cases ultrarapid LR-GS led to immediate adjustments in patient care, e.g., medication switch or termination of treatment. Our findings underscore the clinical impact of ultrarapid LR-GS, including added value of methylation analysis, for critically ill patients and highlight existing challenges, paving the way to ultrarapid LR-GS integration into standard diagnostics.

European Journal of Human GeneticsVol. 34(1)
Radboud University Nijmegen (NL), Utrecht University (NL), Leiden University Medical Center (NL), Erasmus MC (NL), Radboud University Medical Center (NL), Vincent Van Gogh Voor Geestelijke Gezondheidszorg (NL), Willem-Alexander Kinderziekenhuis (NL), Erasmus MC - Sophia Children’s Hospital (NL), Wilhelmina Children's Hospital (NL), Erasmus University Rotterdam (NL)
ZonMw, Hospital for Sick Children
Openalex Percentile: Top 4%
Genomics and Rare Diseases
5.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.